Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy
Authors
Keywords
-
Journal
Acta Pharmaceutica Sinica B
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-07-21
DOI
10.1016/j.apsb.2022.07.011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Co-delivery of doxorubicin and CRISPR/Cas9 or RNAi-expressing plasmid by chitosan-based nanoparticle for cancer therapy
- (2022) Qiuping Li et al. CARBOHYDRATE POLYMERS
- Ionizable lipid nanoparticles for in utero mRNA delivery
- (2021) Rachel S. Riley et al. Science Advances
- Recent Advances in Oligonucleotide Therapeutics in Oncology
- (2021) Haoyu Xiong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Lipid Nanoparticle-Mediated Delivery of mRNA Therapeutics and Vaccines
- (2021) Kelsey L. Swingle et al. TRENDS IN MOLECULAR MEDICINE
- Polymeric Nanocarriers: A Transformation in Doxorubicin Therapies
- (2021) Kamila Butowska et al. Materials
- Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
- (2021) Thai Thanh Hoang Thi et al. Vaccines
- Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device
- (2021) Sarah J. Shepherd et al. NANO LETTERS
- Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)
- (2021) Alison R. Walker et al. Blood Advances
- An ionizable lipid toolbox for RNA delivery
- (2021) Xuexiang Han et al. Nature Communications
- Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
- (2020) Margaret M. Billingsley et al. NANO LETTERS
- The COVID-19 vaccine development landscape
- (2020) Tung Thanh Le et al. NATURE REVIEWS DRUG DISCOVERY
- Nanoparticle-encapsulated siRNAs for gene silencing in the haematopoietic stem-cell niche
- (2020) Marvin Krohn-Grimberghe et al. Nature Biomedical Engineering
- Engineering precision nanoparticles for drug delivery
- (2020) Michael J. Mitchell et al. NATURE REVIEWS DRUG DISCOVERY
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting the Bcl-2 Family in B Cell Lymphoma
- (2019) Clare M. Adams et al. Frontiers in Oncology
- Lipid-based nanoparticle formulations for small molecules and RNA drugs
- (2019) Ludger M. Ickenstein et al. Expert Opinion on Drug Delivery
- Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening
- (2019) Pedro P.G. Guimaraes et al. JOURNAL OF CONTROLLED RELEASE
- The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
- (2019) Akin Akinc et al. Nature Nanotechnology
- Nanoparticles for Immune Cytokine TRAIL-Based Cancer Therapy
- (2018) Pedro P.G. Guimarães et al. ACS Nano
- Advances in Biomaterials for Drug Delivery
- (2018) Owen S. Fenton et al. ADVANCED MATERIALS
- Co-Delivery of Doxorubicin and Anti-BCL-2 siRNA by pH-Responsive Polymeric Vector to Overcome Drug Resistance in In Vitro and In Vivo HepG2 Hepatoma Model
- (2018) Weitong Sun et al. BIOMACROMOLECULES
- Cancer cell behaviors mediated by dysregulated pH dynamics at a glance
- (2017) Katharine A. White et al. JOURNAL OF CELL SCIENCE
- Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy
- (2017) Zhengxiong Li et al. PHARMACEUTICAL RESEARCH
- Thiol–maleimide “click” chemistry: evaluating the influence of solvent, initiator, and thiol on the reaction mechanism, kinetics, and selectivity
- (2015) Brian H. Northrop et al. Polymer Chemistry
- Insight into Mechanisms of Cellular Uptake of Lipid Nanoparticles and Intracellular Release of Small RNAs
- (2014) Bo Yu et al. PHARMACEUTICAL RESEARCH
- Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
- (2014) Kathryn A. Whitehead et al. Nature Communications
- In Vitro–In Vivo Translation of Lipid Nanoparticles for Hepatocellular siRNA Delivery
- (2012) Kathryn A. Whitehead et al. ACS Nano
- E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells
- (2012) Michael J. Mitchell et al. JOURNAL OF CONTROLLED RELEASE
- Nanostructured Surfaces to Target and Kill Circulating Tumor Cells While Repelling Leukocytes
- (2012) Michael J. Mitchell et al. Journal of Nanomaterials
- How does doxorubicin work?
- (2012) Anand G Patel et al. eLife
- Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat
- (2011) Du Cheng et al. BIOMATERIALS
- Control of mitochondrial apoptosis by the Bcl-2 family
- (2009) J. K. Brunelle et al. JOURNAL OF CELL SCIENCE
- Co-delivery of Doxorubicin and Bcl-2 siRNA by Mesoporous Silica Nanoparticles Enhances the Efficacy of Chemotherapy in Multidrug-Resistant Cancer Cells
- (2009) Alex M. Chen et al. Small
- An overview of cancer multidrug resistance: a still unsolved problem
- (2008) H. Lage CELLULAR AND MOLECULAR LIFE SCIENCES
- Bcl-2 family proteins and cancer
- (2008) K W Yip et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started